ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Instadose Pharma Corp. f/k/a Mikrocoze, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INSD, MZKR
NEW YORK, Feb. 05, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Instadose